Latest Headlines

  1. Nordson MEDICAL Introduces PharmaLok™ ZerO: The New Standard In Sanitary Clamps For Biopharma 1/29/2025

    Nordson MEDICAL unveils PharmaLok™ ZerO sanitary clamps, offering 360° uniform compression, universal compatibility, and a compact, user-friendly design to enhance biopharma processes with superior sealing and reduced waste.

  2. Industry-First Solution Revolutionizes CGT Sterile Processing 1/21/2025

    To provide CGT manufacturers with alternatives to using cumbersome biosafety cabinets or tube welding to maintain sterility, CPC (Colder Products Company) introduces the smallest aseptic connector available, the MicroCNX® Nano Series connector.

  3. Registration Opens For INTERPHEX 2025 | April 1-3 In NYC: Learning Lab Conference Schedule, Show Floor Content, And New Features Announced 1/16/2025

    Join thousands of industry professionals at INTERPHEX, the premier pharmaceutical and biotechnology event taking place April 1-3, 2025, at the Javits Center in NYC. Here, attendees gain direct access to the tools they need to effectively accelerate their drug-to-market journey.

  4. ILC Dover Unveils Sentinel XT™ Horizon For Innovative Respiratory Protection With Unmatched Comfort & Safety 1/14/2025

    ILC Dover (“ILC Dover” or the “Company”), an Ingersoll Rand Business and world leader in innovative protective solutions, announced the launch of Sentinel XT™ Horizon. This latest addition to the Sentinel XT™ line of Powered Air-Purifying Respirators (PAPRs) sets a new benchmark in respiratory protection, combining exceptional safety features with unparalleled ease of use.

  5. Nucleus Biologics Becomes First Custom Cell Culture Media Company To Achieve EXCiPACT Certification For The Manufacture Of Excipient GMP Quality Cell Culture Media, Supplements, And Buffers 1/9/2025

    Nucleus Biologics, a leader in precision cell culture media development, is proud to announce that it has achieved an industry-leading quality milestone. It has received EXCiPACT certification for Pharmaceutical Excipients and Pharmaceutical Auxiliary Materials (PAMs) and ISO 9001 certification from SGS.

  6. CRB Announces Exhibition And Speaker Schedule For Advanced Therapies Week 2025 1/9/2025

    Attending the show? Make sure to meet CRB’s team of cell and gene therapy specialists at Advanced Therapies Week in booth 566. CRB’s subject matter expert, Peter Walters, will be presenting an educational seminar in the session “Developing Future Facilities While Supporting the Advanced Therapies Ecosystem."

  7. Abzena Strengthens Board With Appointment Of Biopharma Industry Leader, Dr. Moncef Slaoui 1/8/2025
    Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, has today announced the appointment of Moncef Slaoui, Ph.D., to its Board of Directors.

  8. AES Clean Technology Names Former CRB Executive To Drive Western Region Growth 12/20/2024

    AES Clean Technology, a leading provider of high-performance cleanroom facilities, has today announced the appointment of Jeff Rozelle as Senior Vice President of Business Development, West Region.

  9. Abzena Expands Analytical Capabilities To Include GMP Cell-Based Potency Testing Across US & UK Sites 11/19/2024

    Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, announced the expansion of their early and late phase analytical capabilities to now include GMP cell-based potency assays at their Cambridge, UK and San Diego, CA development and manufacturing facilities.

  10. MilliporeSigma Invests $76 Million To Expand ADC Manufacturing For Novel Cancer Therapies 11/6/2024

    MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, today announced a $76 million expansion of its ADC manufacturing capabilities and capacity at its Bioconjugation Center of Excellence facility in St. Louis, Missouri. This investment will triple existing capacity and enhance the company’s contract development and manufacturing organization (CDMO) offering, reinforcing its commitment to clients and patients.